Neumora Therapeutics (NMRA) P/E (2023 - 2026)
Neumora Therapeutics (NMRA) P/E from Sep 14, 2023 to Jul 20, 2026. The TTM Neumora Therapeutics (NMRA) P/E is -1.17. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Neumora Therapeutics (NMRA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.17 | +1.34% |
| 2025 | -1.15 | -74.99% |
| 2024 | -4.61 | +26.87% |
| 2023 | -3.63 | N/A |
Comparison Neumora Therapeutics (NMRA) P/E with competitors
Neumora Therapeutics (NMRA) P/E is -1.17.